SHENZHEN, China, July 21 /PRNewswire-Asia-FirstCall/ -- Domain Registration Corp. (OTC Bulletin Board: DOMR), today announces that the Company has changed its name to "BioPharm Asia, Inc." effective July 17, 2009. A corresponding ticker change will take place in the next three to four weeks in accordance with FINRA policy.
The name change to BioPharm Asia, Inc. will be reflected in SEC filings and all future corporate communications with the investor community, including press releases and the Company's new and evolving website: http://www.biopharmasiainc.com .
"In order to more accurately reflect our Company's broad initiatives into the pharmaceutical and medical markets, we have changed our corporate name to BioPharm Asia, Inc.," said Yunlu Yin, Chief Executive Officer. "As demonstrated by our recent announcement of 360 new retail stores opening across China's Northeast, we are committed to become a leading supplier and distributor of high quality pharmaceutical and herbal products and addressing the rising demand for these medicines throughout China. We look forward to updating our loyal shareholders and prospective investors on BioPharm Asia's exciting developments in the coming weeks and months."
About BioPharm Asia, Inc.
BioPharm Asia, Inc. is primarily engaged in the retail sale of medical products in China, complemented by a vertically integrated supporting function that includes the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. Following several successful acquisitions, the Company is completing the integration of its distribution channels, and expanding its trading business (conducted through its retail stores, and its distribution and wholesale activities) to include pharmaceutical manufacturing and the cultivation and sale of medicinal raw materials. For more information, please visit http://www.biopharmasiainc.com .
Forward-looking statement: Except for the historical information, the matters discussed in this news release may contain forward-looking statements, including, but not limited to, factors relating to future sales. These forward-looking statements may involve a number of risks and uncertainties. Actual results may differ materially based on a number of factors, including, but not limited to, uncertainties in product demand, risks related to doing business in China, the impact of competitive products and pricing, changing economic conditions around the world, release and sales of new products and other risk factors detailed in the company's most recent annual report and other filings with the Securities and Exchange Commission.
For more information, please contact: BioPharm Asia, Inc. Lijun Zhang Tel: +1-718-705-4217 Email: firstname.lastname@example.org
|SOURCE BioPharm Asia, Inc.|
Copyright©2009 PR Newswire.
All rights reserved